Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "TransMIT"

51 News Found

Upsurge in pink eye conjunctivitis cases in the country
Healthcare | July 29, 2023

Upsurge in pink eye conjunctivitis cases in the country

Take proper precautions and seek timely treatment!


GSK receives USFDA Fast Track designation for investigational vaccine against gonorrhoea
News | June 28, 2023

GSK receives USFDA Fast Track designation for investigational vaccine against gonorrhoea

Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing


Zydus receives final approval from the USFDA for Azithromycin Tablets
Drug Approval | April 11, 2023

Zydus receives final approval from the USFDA for Azithromycin Tablets

Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States


Serum Institute of India likely front-runner to win supply of HPV vaccines for UIP, says GlobalData
News | March 21, 2023

Serum Institute of India likely front-runner to win supply of HPV vaccines for UIP, says GlobalData

The Indian government will float a global tender in April 2023 to procure HPV vaccines.


Vidita Vaidya awarded Infosys Prize 2022 in Life Sciences
News | January 10, 2023

Vidita Vaidya awarded Infosys Prize 2022 in Life Sciences

In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual


Rupala to inaugurate 29 MVUs and centralised call center in Thiruvananthapuram
Healthcare | January 05, 2023

Rupala to inaugurate 29 MVUs and centralised call center in Thiruvananthapuram

MVUs will provide diagnosis treatment, vaccination, artificial insemination, minor surgical interventions, audio-visual aids and extension services to farmers/animal owners at their doorstep in far flung areas.


Synchron raises $75 mn Series C Led by ARCH Venture Partners
News | December 16, 2022

Synchron raises $75 mn Series C Led by ARCH Venture Partners

Gates Frontier, Bezos Expeditions, Reliance Digital Health Limited, Greenoaks, Alumni Ventures, Moore Strategic Ventures, and Project X join ARCH as new additional investors


USFDA grants priority review of BLA for dengue vaccine TAK-003
Drug Approval | November 23, 2022

USFDA grants priority review of BLA for dengue vaccine TAK-003

If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers


LANXESS to showcase Biosecurity Solutions at EuroTier 2022
News | November 10, 2022

LANXESS to showcase Biosecurity Solutions at EuroTier 2022

The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products


Apollo launches automated AI based patient monitoring system
Digitisation | October 15, 2022

Apollo launches automated AI based patient monitoring system

This will dramatically improve timely intervention with the right experts thus ensuring significant improvement in patient’s condition management and health outcome